News story

Latest topics referred to NICE: September 2011

This news article was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE).

Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE) in September, to begin the process of developing guidance for each topic.

Technology appraisals

These are the technology appraisals that have been referred to NICE.

  • To appraise the clinical and cost effectiveness of ridaforolimus within its licensed indication for the maintenance treatment of metastatic soft tissue or bone sarcoma.
  • To appraise the clinical and cost effectiveness of ivabradine within its licensed indication for the treatment of chronic heart failure.
  • To appraise the clinical and cost effectiveness of vemurafenib within its licensed indication for the treatment of unresectable locally advanced or metastatic BRAFV600 mutation-positive malignant melanoma.
  • To appraise the clinical and cost effectiveness of bevacizumab within its licensed indication in combination with chemotherapy for the second line treatment of human epidermal growth factor 2 (HER2) negative metastatic breast cancer.
  • To appraise the clinical and cost effectiveness of bevacizumab within its licensed indication for the treatment of platinum-sensitive or partially platinum-sensitive recurrent advanced ovarian cancer (including fallopian tube and primary peritoneal cancer).

Find out more about NICE technology appraisals on the NICE website.

About NICE referrals

NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.

Department of Health ministers refer topics to NICE and NICE schedules these topics into its work programme, to begin the process of developing guidance for each topic.

Depending on the type of guidance and its complexity, this can take between 6 months and 2 years.

NICE guidance includes technology appraisals, clinical guidelines, public health guidelines and quality standards.

Find out more about NICE guidance on the NICE website.